Jump to section
Biobot Analytics develops cutting-edge technology to transform sewers into public health observatories.
21% employee growth in 12 months
Public health analytics are vital for preventing and tackling some of society's biggest challenges, including disease and opioid addiction. Biobot solves this problem by analyzing waste water.
Biobot's founding team boasts experience in both architecture and science, which has shaped its technology considerably. The company was founded in 2017, and initially focused on the opioid epidemic, collecting wastewater data to give a more accurate insight into the issue. During the COVID-19 pandemic, Biobot saw its technology used for a wider variety of applications. This was a solid test of the company's adaptability and scalability.
Biobot's main challenge will be competing with traditional forms of public health data analysis. However, its approach offers an unbiased and completely anonymized means of monitoring public health, infectious diseases and drug use. This will likely give Biobot an edge as it seeks to expand into new territories.
Freddie
Company Specialist at Welcome to the Jungle
Sep 2024
$30m
EARLY VC
Nov 2022
$20m
SERIES A
This company has top investors
Mariana Matus
(CEO)Was a Research Intern at the University of Cambridge, and a PhD Researcher at MIT.
Newsha Ghaeli
(President)Started out as a Junior Architect at Carlo Ratti Associati, and was Research Associate & Project Lead at MIT Senseable City Lab. Is a Venture Partner at Pioneer Fund.